Expression of MiR-608 in Nonsmall Cell Lung Cancer and Molecular Mechanism of Apoptosis and Migration of A549 Cells
Objective. This Work is aimed at exploring the effect of microRNA (MiR)-608 on the function of nonsmall cell lung cancer (NSCLC) A549 cells and related mechanisms. Methods. Blood samples of 106 NSCLC patients (experimental group) as well as 124 normal people (control group) were selected for relevan...
Gespeichert in:
Veröffentlicht in: | BioMed research international 2020, Vol.2020 (2020), p.1-8 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 8 |
---|---|
container_issue | 2020 |
container_start_page | 1 |
container_title | BioMed research international |
container_volume | 2020 |
creator | Tian, Hui Lu, Ming Qi, Lei Si, Libo Gao, Cun Li, Shuhai Li, Lin Yue, Weiming Huang, Chu Cheng, Chuanle |
description | Objective. This Work is aimed at exploring the effect of microRNA (MiR)-608 on the function of nonsmall cell lung cancer (NSCLC) A549 cells and related mechanisms. Methods. Blood samples of 106 NSCLC patients (experimental group) as well as 124 normal people (control group) were selected for relevant investigation. Polymerase chain reaction (PCR) as well as DNA sequencing was used to determine the genotyping of the MiR-608 rs4919510 polymorphism. MiR-608 expression in cells was detected by real-time PCR technology. Western blotting was used to detect changes in protein levels. NSCLC tissues as well as adjacent tissues were explored in 33 patients undergoing surgery. Results. MiR-608 rs4919510 does not influence the incidence of NSCLC patients. In addition, MiR-608 expression was downregulated in the tumor tissue of NSCLC patients, while the transcription factor activating enhancer-binding protein 4 (TFAP4) expression was upregulated. MiR-608 promotes DOX- (Doxorubicin-) induced apoptosis by negatively regulating TFAP4 expression in NSCLC tissue. TFAP4 can significantly inhibit the migration of A549 cells. Conclusion. The findings in this investigation can contribute to the effective treatment of NSCLC patients. Also, the investigation can provide some theoretical support for the application of new targets for NSCLC treatment. |
doi_str_mv | 10.1155/2020/8824519 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7773458</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A683547047</galeid><sourcerecordid>A683547047</sourcerecordid><originalsourceid>FETCH-LOGICAL-c527t-3ee2448e96a432b58b188bcfe980d11622f5b49e312d9a5463c633f0289a9aba3</originalsourceid><addsrcrecordid>eNqNkc1rFDEYhwdRbGl78ywBjzo23x8XYVlaFXYVRM8hk8nspswkYzJT2_--2e661YuYw5sX3icPb_hV1SsE3yPE2CWGGF5KiSlD6ll1igmiNUcUPT_2hJxUFznfwHIk4lDxl9UJIRRzKPBpla_uxuRy9jGA2IG1_1ZzKIEP4EsMeTB9D5aulNUcNmBpgnUJmNCCdeydnXuTwNrZrQk-D7v3izGOU8w-7yG_SWY6qBeMqkdXPq9edKbP7uJwn1U_rq--Lz_Vq68fPy8Xq9oyLKaaOIcplU5xQwlumGyQlI3tnJKwRYhj3LGGKkcQbpVhlBPLCekglsoo0xhyVn3Ye8e5GVxrXZiS6fWY_GDSvY7G678nwW_1Jt5qIQShTBbBm4MgxZ-zy5O-iXMKZWeNqaCSIwT5E7UxvdM-dLHI7OCz1QuuWDExwv5NScKogFQU6t2esinmnFx33BZBvUtc7xLXh8QL_vrPHx7h3_kW4O0e2PrQml_-P3WuMK4zTzQigitJHgAwlLkI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2474861106</pqid></control><display><type>article</type><title>Expression of MiR-608 in Nonsmall Cell Lung Cancer and Molecular Mechanism of Apoptosis and Migration of A549 Cells</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>PubMed Central Open Access</source><creator>Tian, Hui ; Lu, Ming ; Qi, Lei ; Si, Libo ; Gao, Cun ; Li, Shuhai ; Li, Lin ; Yue, Weiming ; Huang, Chu ; Cheng, Chuanle</creator><contributor>Xu, Zhenbo ; Zhenbo Xu</contributor><creatorcontrib>Tian, Hui ; Lu, Ming ; Qi, Lei ; Si, Libo ; Gao, Cun ; Li, Shuhai ; Li, Lin ; Yue, Weiming ; Huang, Chu ; Cheng, Chuanle ; Xu, Zhenbo ; Zhenbo Xu</creatorcontrib><description>Objective. This Work is aimed at exploring the effect of microRNA (MiR)-608 on the function of nonsmall cell lung cancer (NSCLC) A549 cells and related mechanisms. Methods. Blood samples of 106 NSCLC patients (experimental group) as well as 124 normal people (control group) were selected for relevant investigation. Polymerase chain reaction (PCR) as well as DNA sequencing was used to determine the genotyping of the MiR-608 rs4919510 polymorphism. MiR-608 expression in cells was detected by real-time PCR technology. Western blotting was used to detect changes in protein levels. NSCLC tissues as well as adjacent tissues were explored in 33 patients undergoing surgery. Results. MiR-608 rs4919510 does not influence the incidence of NSCLC patients. In addition, MiR-608 expression was downregulated in the tumor tissue of NSCLC patients, while the transcription factor activating enhancer-binding protein 4 (TFAP4) expression was upregulated. MiR-608 promotes DOX- (Doxorubicin-) induced apoptosis by negatively regulating TFAP4 expression in NSCLC tissue. TFAP4 can significantly inhibit the migration of A549 cells. Conclusion. The findings in this investigation can contribute to the effective treatment of NSCLC patients. Also, the investigation can provide some theoretical support for the application of new targets for NSCLC treatment.</description><identifier>ISSN: 2314-6133</identifier><identifier>EISSN: 2314-6141</identifier><identifier>DOI: 10.1155/2020/8824519</identifier><identifier>PMID: 33426072</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>A549 Cells ; Analysis ; Antineoplastic Agents - pharmacology ; Apoptosis ; Apoptosis - drug effects ; Apoptosis - genetics ; Carcinoma, Non-Small-Cell Lung - genetics ; Carcinoma, Non-Small-Cell Lung - metabolism ; Cell culture ; Cell migration ; Cell Movement - drug effects ; Cell Movement - genetics ; Deoxyribonucleic acid ; DNA ; DNA sequencing ; Doxorubicin ; Doxorubicin - pharmacology ; Gastric cancer ; Gene expression ; Gene Expression Regulation, Neoplastic - drug effects ; Gene Expression Regulation, Neoplastic - genetics ; Genetic aspects ; Genetic polymorphisms ; Genotyping ; Health aspects ; Humans ; Identification and classification ; Lung cancer ; Lung cancer, Non-small cell ; Lung Neoplasms - genetics ; Lung Neoplasms - metabolism ; Metastasis ; Methods ; MicroRNA ; MicroRNAs ; MicroRNAs - genetics ; MicroRNAs - metabolism ; miRNA ; Morbidity ; Non-small cell lung carcinoma ; Nucleotide sequencing ; Patients ; Physiological aspects ; Polymerase chain reaction ; Polymorphism ; Properties ; Proteins ; Ribonucleic acid ; RNA ; Surgery ; Tissues ; Tumors ; Western blotting ; Western immunoblotting</subject><ispartof>BioMed research international, 2020, Vol.2020 (2020), p.1-8</ispartof><rights>Copyright © 2020 Chu Huang et al.</rights><rights>COPYRIGHT 2020 John Wiley & Sons, Inc.</rights><rights>Copyright © 2020 Chu Huang et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0</rights><rights>Copyright © 2020 Chu Huang et al. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c527t-3ee2448e96a432b58b188bcfe980d11622f5b49e312d9a5463c633f0289a9aba3</citedby><cites>FETCH-LOGICAL-c527t-3ee2448e96a432b58b188bcfe980d11622f5b49e312d9a5463c633f0289a9aba3</cites><orcidid>0000-0003-3564-1812 ; 0000-0003-4516-2313</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773458/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773458/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,4010,27900,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33426072$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Xu, Zhenbo</contributor><contributor>Zhenbo Xu</contributor><creatorcontrib>Tian, Hui</creatorcontrib><creatorcontrib>Lu, Ming</creatorcontrib><creatorcontrib>Qi, Lei</creatorcontrib><creatorcontrib>Si, Libo</creatorcontrib><creatorcontrib>Gao, Cun</creatorcontrib><creatorcontrib>Li, Shuhai</creatorcontrib><creatorcontrib>Li, Lin</creatorcontrib><creatorcontrib>Yue, Weiming</creatorcontrib><creatorcontrib>Huang, Chu</creatorcontrib><creatorcontrib>Cheng, Chuanle</creatorcontrib><title>Expression of MiR-608 in Nonsmall Cell Lung Cancer and Molecular Mechanism of Apoptosis and Migration of A549 Cells</title><title>BioMed research international</title><addtitle>Biomed Res Int</addtitle><description>Objective. This Work is aimed at exploring the effect of microRNA (MiR)-608 on the function of nonsmall cell lung cancer (NSCLC) A549 cells and related mechanisms. Methods. Blood samples of 106 NSCLC patients (experimental group) as well as 124 normal people (control group) were selected for relevant investigation. Polymerase chain reaction (PCR) as well as DNA sequencing was used to determine the genotyping of the MiR-608 rs4919510 polymorphism. MiR-608 expression in cells was detected by real-time PCR technology. Western blotting was used to detect changes in protein levels. NSCLC tissues as well as adjacent tissues were explored in 33 patients undergoing surgery. Results. MiR-608 rs4919510 does not influence the incidence of NSCLC patients. In addition, MiR-608 expression was downregulated in the tumor tissue of NSCLC patients, while the transcription factor activating enhancer-binding protein 4 (TFAP4) expression was upregulated. MiR-608 promotes DOX- (Doxorubicin-) induced apoptosis by negatively regulating TFAP4 expression in NSCLC tissue. TFAP4 can significantly inhibit the migration of A549 cells. Conclusion. The findings in this investigation can contribute to the effective treatment of NSCLC patients. Also, the investigation can provide some theoretical support for the application of new targets for NSCLC treatment.</description><subject>A549 Cells</subject><subject>Analysis</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis - genetics</subject><subject>Carcinoma, Non-Small-Cell Lung - genetics</subject><subject>Carcinoma, Non-Small-Cell Lung - metabolism</subject><subject>Cell culture</subject><subject>Cell migration</subject><subject>Cell Movement - drug effects</subject><subject>Cell Movement - genetics</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA sequencing</subject><subject>Doxorubicin</subject><subject>Doxorubicin - pharmacology</subject><subject>Gastric cancer</subject><subject>Gene expression</subject><subject>Gene Expression Regulation, Neoplastic - drug effects</subject><subject>Gene Expression Regulation, Neoplastic - genetics</subject><subject>Genetic aspects</subject><subject>Genetic polymorphisms</subject><subject>Genotyping</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Identification and classification</subject><subject>Lung cancer</subject><subject>Lung cancer, Non-small cell</subject><subject>Lung Neoplasms - genetics</subject><subject>Lung Neoplasms - metabolism</subject><subject>Metastasis</subject><subject>Methods</subject><subject>MicroRNA</subject><subject>MicroRNAs</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - metabolism</subject><subject>miRNA</subject><subject>Morbidity</subject><subject>Non-small cell lung carcinoma</subject><subject>Nucleotide sequencing</subject><subject>Patients</subject><subject>Physiological aspects</subject><subject>Polymerase chain reaction</subject><subject>Polymorphism</subject><subject>Properties</subject><subject>Proteins</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>Surgery</subject><subject>Tissues</subject><subject>Tumors</subject><subject>Western blotting</subject><subject>Western immunoblotting</subject><issn>2314-6133</issn><issn>2314-6141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkc1rFDEYhwdRbGl78ywBjzo23x8XYVlaFXYVRM8hk8nspswkYzJT2_--2e661YuYw5sX3icPb_hV1SsE3yPE2CWGGF5KiSlD6ll1igmiNUcUPT_2hJxUFznfwHIk4lDxl9UJIRRzKPBpla_uxuRy9jGA2IG1_1ZzKIEP4EsMeTB9D5aulNUcNmBpgnUJmNCCdeydnXuTwNrZrQk-D7v3izGOU8w-7yG_SWY6qBeMqkdXPq9edKbP7uJwn1U_rq--Lz_Vq68fPy8Xq9oyLKaaOIcplU5xQwlumGyQlI3tnJKwRYhj3LGGKkcQbpVhlBPLCekglsoo0xhyVn3Ye8e5GVxrXZiS6fWY_GDSvY7G678nwW_1Jt5qIQShTBbBm4MgxZ-zy5O-iXMKZWeNqaCSIwT5E7UxvdM-dLHI7OCz1QuuWDExwv5NScKogFQU6t2esinmnFx33BZBvUtc7xLXh8QL_vrPHx7h3_kW4O0e2PrQml_-P3WuMK4zTzQigitJHgAwlLkI</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Tian, Hui</creator><creator>Lu, Ming</creator><creator>Qi, Lei</creator><creator>Si, Libo</creator><creator>Gao, Cun</creator><creator>Li, Shuhai</creator><creator>Li, Lin</creator><creator>Yue, Weiming</creator><creator>Huang, Chu</creator><creator>Cheng, Chuanle</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley & Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3564-1812</orcidid><orcidid>https://orcid.org/0000-0003-4516-2313</orcidid></search><sort><creationdate>2020</creationdate><title>Expression of MiR-608 in Nonsmall Cell Lung Cancer and Molecular Mechanism of Apoptosis and Migration of A549 Cells</title><author>Tian, Hui ; Lu, Ming ; Qi, Lei ; Si, Libo ; Gao, Cun ; Li, Shuhai ; Li, Lin ; Yue, Weiming ; Huang, Chu ; Cheng, Chuanle</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c527t-3ee2448e96a432b58b188bcfe980d11622f5b49e312d9a5463c633f0289a9aba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>A549 Cells</topic><topic>Analysis</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis - genetics</topic><topic>Carcinoma, Non-Small-Cell Lung - genetics</topic><topic>Carcinoma, Non-Small-Cell Lung - metabolism</topic><topic>Cell culture</topic><topic>Cell migration</topic><topic>Cell Movement - drug effects</topic><topic>Cell Movement - genetics</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA sequencing</topic><topic>Doxorubicin</topic><topic>Doxorubicin - pharmacology</topic><topic>Gastric cancer</topic><topic>Gene expression</topic><topic>Gene Expression Regulation, Neoplastic - drug effects</topic><topic>Gene Expression Regulation, Neoplastic - genetics</topic><topic>Genetic aspects</topic><topic>Genetic polymorphisms</topic><topic>Genotyping</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Identification and classification</topic><topic>Lung cancer</topic><topic>Lung cancer, Non-small cell</topic><topic>Lung Neoplasms - genetics</topic><topic>Lung Neoplasms - metabolism</topic><topic>Metastasis</topic><topic>Methods</topic><topic>MicroRNA</topic><topic>MicroRNAs</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - metabolism</topic><topic>miRNA</topic><topic>Morbidity</topic><topic>Non-small cell lung carcinoma</topic><topic>Nucleotide sequencing</topic><topic>Patients</topic><topic>Physiological aspects</topic><topic>Polymerase chain reaction</topic><topic>Polymorphism</topic><topic>Properties</topic><topic>Proteins</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>Surgery</topic><topic>Tissues</topic><topic>Tumors</topic><topic>Western blotting</topic><topic>Western immunoblotting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tian, Hui</creatorcontrib><creatorcontrib>Lu, Ming</creatorcontrib><creatorcontrib>Qi, Lei</creatorcontrib><creatorcontrib>Si, Libo</creatorcontrib><creatorcontrib>Gao, Cun</creatorcontrib><creatorcontrib>Li, Shuhai</creatorcontrib><creatorcontrib>Li, Lin</creatorcontrib><creatorcontrib>Yue, Weiming</creatorcontrib><creatorcontrib>Huang, Chu</creatorcontrib><creatorcontrib>Cheng, Chuanle</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BioMed research international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tian, Hui</au><au>Lu, Ming</au><au>Qi, Lei</au><au>Si, Libo</au><au>Gao, Cun</au><au>Li, Shuhai</au><au>Li, Lin</au><au>Yue, Weiming</au><au>Huang, Chu</au><au>Cheng, Chuanle</au><au>Xu, Zhenbo</au><au>Zhenbo Xu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of MiR-608 in Nonsmall Cell Lung Cancer and Molecular Mechanism of Apoptosis and Migration of A549 Cells</atitle><jtitle>BioMed research international</jtitle><addtitle>Biomed Res Int</addtitle><date>2020</date><risdate>2020</risdate><volume>2020</volume><issue>2020</issue><spage>1</spage><epage>8</epage><pages>1-8</pages><issn>2314-6133</issn><eissn>2314-6141</eissn><abstract>Objective. This Work is aimed at exploring the effect of microRNA (MiR)-608 on the function of nonsmall cell lung cancer (NSCLC) A549 cells and related mechanisms. Methods. Blood samples of 106 NSCLC patients (experimental group) as well as 124 normal people (control group) were selected for relevant investigation. Polymerase chain reaction (PCR) as well as DNA sequencing was used to determine the genotyping of the MiR-608 rs4919510 polymorphism. MiR-608 expression in cells was detected by real-time PCR technology. Western blotting was used to detect changes in protein levels. NSCLC tissues as well as adjacent tissues were explored in 33 patients undergoing surgery. Results. MiR-608 rs4919510 does not influence the incidence of NSCLC patients. In addition, MiR-608 expression was downregulated in the tumor tissue of NSCLC patients, while the transcription factor activating enhancer-binding protein 4 (TFAP4) expression was upregulated. MiR-608 promotes DOX- (Doxorubicin-) induced apoptosis by negatively regulating TFAP4 expression in NSCLC tissue. TFAP4 can significantly inhibit the migration of A549 cells. Conclusion. The findings in this investigation can contribute to the effective treatment of NSCLC patients. Also, the investigation can provide some theoretical support for the application of new targets for NSCLC treatment.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>33426072</pmid><doi>10.1155/2020/8824519</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-3564-1812</orcidid><orcidid>https://orcid.org/0000-0003-4516-2313</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2314-6133 |
ispartof | BioMed research international, 2020, Vol.2020 (2020), p.1-8 |
issn | 2314-6133 2314-6141 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7773458 |
source | MEDLINE; Wiley Online Library Open Access; PubMed Central; Alma/SFX Local Collection; PubMed Central Open Access |
subjects | A549 Cells Analysis Antineoplastic Agents - pharmacology Apoptosis Apoptosis - drug effects Apoptosis - genetics Carcinoma, Non-Small-Cell Lung - genetics Carcinoma, Non-Small-Cell Lung - metabolism Cell culture Cell migration Cell Movement - drug effects Cell Movement - genetics Deoxyribonucleic acid DNA DNA sequencing Doxorubicin Doxorubicin - pharmacology Gastric cancer Gene expression Gene Expression Regulation, Neoplastic - drug effects Gene Expression Regulation, Neoplastic - genetics Genetic aspects Genetic polymorphisms Genotyping Health aspects Humans Identification and classification Lung cancer Lung cancer, Non-small cell Lung Neoplasms - genetics Lung Neoplasms - metabolism Metastasis Methods MicroRNA MicroRNAs MicroRNAs - genetics MicroRNAs - metabolism miRNA Morbidity Non-small cell lung carcinoma Nucleotide sequencing Patients Physiological aspects Polymerase chain reaction Polymorphism Properties Proteins Ribonucleic acid RNA Surgery Tissues Tumors Western blotting Western immunoblotting |
title | Expression of MiR-608 in Nonsmall Cell Lung Cancer and Molecular Mechanism of Apoptosis and Migration of A549 Cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T13%3A11%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20MiR-608%20in%20Nonsmall%20Cell%20Lung%20Cancer%20and%20Molecular%20Mechanism%20of%20Apoptosis%20and%20Migration%20of%20A549%20Cells&rft.jtitle=BioMed%20research%20international&rft.au=Tian,%20Hui&rft.date=2020&rft.volume=2020&rft.issue=2020&rft.spage=1&rft.epage=8&rft.pages=1-8&rft.issn=2314-6133&rft.eissn=2314-6141&rft_id=info:doi/10.1155/2020/8824519&rft_dat=%3Cgale_pubme%3EA683547047%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2474861106&rft_id=info:pmid/33426072&rft_galeid=A683547047&rfr_iscdi=true |